0000899243-20-009971.txt : 20200402 0000899243-20-009971.hdr.sgml : 20200402 20200402152535 ACCESSION NUMBER: 0000899243-20-009971 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200402 DATE AS OF CHANGE: 20200402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fox Judith A. CENTRAL INDEX KEY: 0001771601 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 20768668 MAIL ADDRESS: STREET 1: SUNESIS PHARMACEUTICALS, INC. STREET 2: 395 OYSTER POINT BOULEVARD, SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-31 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001771601 Fox Judith A. SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BOULEVARD, STE. 400 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 See Remarks Stock Option (Right to Buy) 0.4149 2020-03-31 4 A 0 457500 0.00 A 2030-03-31 Common Stock 457500 457500 D One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of March 31, 2020. Thereafter, one forty-eighth (1/48th) of shares granted shall vest monthly over the next thirty-six (36) months. Chief Scientific Officer, Executive V.P. Research & Development /s/ Tina Gullotta (Attorney-in-Fact) 2020-04-02